NSE filing, NSE: MEDPLUS. Summary written from the filing by ALFA Finder's alert engine.
Medplus Health Services Ltd: key numbers
- Share price
- ₹579.90
- Market cap
- ₹6,968 Cr
- Revenue (annual)
- ₹6,892 Cr
- Net profit (annual)
- ₹219.7 Cr
- P/E (TTM)
- 33.0×Sector 52.3×
- Promoter holding
- 40.19%+0.00% QoQ
- FII holding
- 12.58%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medplus Health Services Ltd
All →Medplus Health Services Board Meeting Date
MedPlus Health Services scheduled a board meeting for 6 November 2026 to consider a share buy-back. The trading window for designated persons closes from 30 October 2026.
Medplus Health Services Capital Structure Change
ICICI Prudential Mutual Fund disclosed under Regulation 29(2) that it bought 24,35,693 Medplus shares, lifting its stake to 9.21%. The acquisition was made in the open market, not off-market.
- Promoter stake change
- +1.97%
Medplus Health Services Earnings Call Transcript: Key Takeaways
Medplus reported Q2 revenue of ₹2,037.1 Cr with 21.3% pharmacy growth, but EBITDA margins were hit by state-mandated wage hikes.
- Call
- Guides 10% growth
Medplus Health Services Share Pledge
Catalyst Trusteeship pledged 34,00,000 Medplus Health Services shares (2.83%) as debenture collateral. Total encumbered shares rose to 2,41,50,400 (20.10% of capital).
Medplus Health Services Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹2,037cr (+21.3% YoY), operating EBITDA ₹98cr (4.8% margin), reported PAT ₹56cr (+1% YoY). Store expansion continues; no explicit guidance given.
Medplus Health Services Employee Stock Options
MedPlus allotted 19,095 equity shares to employees on exercise of ESOP 2021 options. Paid-up capital rises to Rs 24.03 Crore.
Other board meeting date announcements
All →Signatureglobal (India) Board Meeting Date
Signatureglobal (India) has scheduled a board meeting on November 5, 2026, to consider unaudited standalone and consolidated results for Q2 and H1 FY2026-27. The trading window stays closed until November 7, 2026.
Mahasagar Travels Board Meeting Date
Mahasagar Travels will hold a board meeting on 5 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window opened 1 October 2026.
Sansera Engineering Board Meeting Date
Sansera Engineering will hold a board meeting on November 5, 2026 to approve unaudited results for the quarter ended September 30, 2026. The trading window for designated persons has been closed since October 1, 2026.
Contil India Board Meeting Date
Contil India will hold a board meeting on 6 November 2026 to consider unaudited standalone half-yearly results. Trading window closed 1 October to 14 November 2026.
GSB Finance Board Meeting Date
Coffers Finvest will hold a board meeting on 4 November 2026 to approve September quarter results. Trading window stays closed until 48 hours after results.
Liotech Industries Board Meeting Date
Liotech Industries will hold a board meeting on November 4, 2026 to consider standalone unaudited results for the half year ended September 30, 2026. The trading window closes from October 1 until 48 hours after the results are declared.